111 related articles for article (PubMed ID: 1407119)
1. [Spasmodic torticollis: a persistent problem].
Brans JW; Speelman JD
Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1737-40. PubMed ID: 1407119
[No Abstract] [Full Text] [Related]
2. Botulinum toxin in spasmodic torticollis.
Tsui JK; Eisen A; Calne DB
Adv Neurol; 1988; 50():593-7. PubMed ID: 3400512
[No Abstract] [Full Text] [Related]
3. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
[No Abstract] [Full Text] [Related]
4. Botulinum toxin treatment of spasmodic torticollis.
Davies L; Lorentz IT
Clin Exp Neurol; 1991; 28():197-8. PubMed ID: 1821827
[No Abstract] [Full Text] [Related]
5. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
Poungvarin N; Viriyavejakul A
J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
[TBL] [Abstract][Full Text] [Related]
6. [Dystonia as the cause of pharyngolaryngeal motility disorders].
Zwirner P; Dressler D
HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
[TBL] [Abstract][Full Text] [Related]
7. Treatment of idiopathic spasmodic torticollis with botulinum-A toxin: a pilot study of 19 patients.
Lorentz IT; Subramaniam SS; Yiannikas C
Med J Aust; 1990 May; 152(10):528-30. PubMed ID: 2338926
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin in cervical dystonia.
Tsui JK; Calne DB
Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
[No Abstract] [Full Text] [Related]
9. [Torticollis versus cervical dystonia].
Erjanti H; Marttila R
Duodecim; 1996; 112(5):393-400. PubMed ID: 10592600
[No Abstract] [Full Text] [Related]
10. Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit.
Yianni J; Bain P; Giladi N; Auca M; Gregory R; Joint C; Nandi D; Stein J; Scott R; Aziz T
Mov Disord; 2003 Apr; 18(4):436-42. PubMed ID: 12671953
[TBL] [Abstract][Full Text] [Related]
11. Botulinum A toxin in spasmodic torticollis.
Ellison DC; Wandres DL
Ann Pharmacother; 1992 Feb; 26(2):216-7. PubMed ID: 1554937
[No Abstract] [Full Text] [Related]
12. The role of polymyography in the treatment of cervical dystonia.
Erro R; Bhatia KP; Esposito M; Cordivari C
J Neurol; 2016 Aug; 263(8):1663-4. PubMed ID: 27314962
[No Abstract] [Full Text] [Related]
13. [Treatment of spasmodic torticollis by local injections of botulinum toxin].
Jedynak CP; de Saint Victor JF
Rev Neurol (Paris); 1990; 146(6-7):440-3. PubMed ID: 2399409
[TBL] [Abstract][Full Text] [Related]
14. Electromyographic guidance of botulinum toxin treatment in cervical dystonia.
Dubinsky RM; Gray CS; Vetere-Overfield B; Koller WC
Clin Neuropharmacol; 1991 Jun; 14(3):262-7. PubMed ID: 2070367
[TBL] [Abstract][Full Text] [Related]
15. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
Adv Neurol; 1988; 50():599-608. PubMed ID: 3400513
[No Abstract] [Full Text] [Related]
16. Clinical features of the geste antagoniste in cervical dystonia.
Filipović SR; Jahanshahi M; Viswanathan R; Heywood P; Rogers D; Bhatia KP
Adv Neurol; 2004; 94():191-201. PubMed ID: 14509673
[No Abstract] [Full Text] [Related]
17. The role of polymyography in the treatment of cervical dystonia: the authors reply.
Jinnah HA; Factor S
J Neurol; 2016 Aug; 263(8):1665. PubMed ID: 27393115
[No Abstract] [Full Text] [Related]
18. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin.
Metzer WS; Jenkins T
J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180
[TBL] [Abstract][Full Text] [Related]
20. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
